Duopharma Biotech Berhad (KLSE: DPHARMA)

Duopharma Biotech Berhad Ratios and Metrics

Market cap in millions MYR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,174	1,212	1,533	1,582	2,386	972
Market Cap Growth	13.33%	-20.94%	-3.10%	-33.70%	145.56%	54.56%
Enterprise Value	1,441	1,522	1,819	1,881	2,521	1,144
Last Close Price	1.22	1.23	1.55	1.59	2.34	0.95
PE Ratio	20.95	22.41	20.93	22.48	37.08	15.40
Forward PE	15.19	14.77	15.91	20.97	34.68	14.59
PS Ratio	1.49	1.72	2.20	2.48	4.19	1.69
PB Ratio	1.69	1.76	2.34	2.54	3.71	1.83
P/TBV Ratio	1.99	1.78	2.35	2.56	3.73	1.84
P/FCF Ratio	16.73	76.43	301.61	-	156.62	71.49
P/OCF Ratio	13.97	24.84	21.82	36.62	33.45	14.51
EV/Sales Ratio	1.83	2.16	2.61	2.94	4.42	1.98
EV/EBITDA Ratio	10.82	13.35	14.80	16.37	23.80	11.38
EV/EBIT Ratio	16.04	19.34	19.57	21.19	30.79	14.81
EV/FCF Ratio	20.54	95.99	357.77	-	165.43	84.16
Debt / Equity Ratio	0.76	0.80	0.66	0.65	0.47	0.50
Debt / EBITDA Ratio	3.96	4.67	3.41	3.41	2.77	2.56
Debt / FCF Ratio	7.52	34.61	84.91	-	19.91	19.57
Asset Turnover	0.58	0.55	0.58	0.58	0.58	0.66
Inventory Turnover	2.14	1.83	1.82	2.06	2.28	2.43
Quick Ratio	3.02	2.59	1.13	1.18	1.95	1.05
Current Ratio	4.33	4.06	2.05	2.15	3.06	1.74
Return on Equity (ROE)	8.18%	7.84%	10.96%	10.36%	9.99%	10.94%
Return on Assets (ROA)	4.10%	3.83%	4.87%	4.99%	5.17%	5.50%
Return on Capital (ROIC)	4.51%	4.24%	5.49%	5.62%	5.87%	6.35%
Earnings Yield	4.77%	4.34%	4.57%	4.15%	2.46%	5.69%
FCF Yield	5.98%	1.31%	0.33%	-4.18%	0.64%	1.40%
Dividend Yield	2.28%	1.87%	1.49%	1.37%	2.08%	4.72%
Payout Ratio	48.04%	16.81%	11.70%	68.45%	12.34%	10.96%
Buyback Yield / Dilution	-0.60%	-1.08%	-2.15%	-0.02%	-3.86%	-2.18%
Total Shareholder Return	1.67%	0.79%	-0.66%	1.35%	-1.78%	2.55%

Source: S&P Capital IQ. Standard template. Financial Sources.